Arcadia Biosciences, Inc. provided earnings guidance for the year 2024. The company anticipated 2024 net operating loss to be under $10 million for the first time in the company's history. The company's first quarter performance and trend has met the expectation in order to deliver that objective, and the company plan to grow revenue, optimize margins and reduce operating expenses for the remainder of 2024 in order to achieve this goal.